ANTM:NYE-Anthem Inc (USD)

COMMON STOCK | Healthcare Plans | NYE

Last Closing Price

USD 478.83

Change

0.00 (0.00)%

Market Cap

USD 116.34B

Volume

0.86M

Avg Analyst Target

USD 580.28 (+21.19%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


ANTM Stock Forecast & Price:
Based on the Anthem Inc stock forecasts from 13 analysts, the average analyst target price for Anthem Inc is USD 580.28 over the next 12 months. Anthem Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Anthem Inc is Very Bullish, which is based on 2 positive signals and 0 negative signals. At the last closing, Anthem Inc’s stock price was USD 478.83. Anthem Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +26.89% over the last year.

About Anthem Inc (ANTM:NYE)

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health be ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-10 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UNH UnitedHealth Group Incorporate..

+0.46 (+0.09%)

USD507.64B 28.35 18.39
CVS CVS Health Corp

+0.36 (+0.35%)

USD134.25B 16.65 11.05
CI Cigna Corp

+2.03 (+0.71%)

USD87.08B 17.03 N/A
HUM Humana Inc

-1.74 (-0.36%)

USD61.73B 19.91 N/A
CNC Centene Corp

+0.05 (+0.05%)

USD54.97B 29.99 13.51
MOH Molina Healthcare Inc

+2.73 (+0.83%)

USD19.04B 25.42 10.68
BHG Bright Health Group Inc

-0.23 (-11.86%)

USD1.28B N/A -0.12
GTS Triple-S Management Corporatio..

N/A

USD0.86B 10.41 N/A

ETFs Containing ANTM

Symbol Name Weight Mer Price(Change) Market Cap
BIV Vanguard Intermediate-Ter.. 0.00 % 0.04 %

+0.26 (+0.33%)

USD32.61B
FSWD:LSE iShares Edge MSCI World M.. 0.00 % 0.55 %

+4.25 (+0.60%)

N/A
XFS-U:CA iShares MSCI Multifactor .. 0.00 % 0.52 %

N/A

N/A
HLGE Hartford Longevity Econom.. 0.00 % 0.44 %

+0.55 (+2.24%)

N/A
TEQI T. Rowe Price Equity Inco.. 0.00 % 0.54 %

+0.52 (+1.52%)

N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.55 %

+0.11 (+1.59%)

USD0.01B
IBCZ:XETRA iShares Edge MSCI World M.. 0.00 % 0.55 %

+0.07 (+0.81%)

USD0.47B
IBCY:XETRA iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

+0.07 (+0.76%)

USD0.12B
IS07:F iShares IV Public Limited.. 0.00 % 0.55 %

+0.06 (+0.85%)

N/A
IBCZ:F iShares IV Public Limited.. 0.00 % 0.55 %

+0.01 (+0.12%)

USD0.46B
IBCY:F iShares IV Public Limited.. 0.00 % 0.35 %

-0.01 (-0.10%)

USD0.12B
UFSD:LSE iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

+0.12 (+1.89%)

USD1.52M
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.55 %

+0.18 (+2.15%)

USD0.47B
IFSU:LSE iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

+0.18 (+1.93%)

USD0.12B
FSUS:LSE iShares Edge MSCI USA Mul.. 0.00 % 0.35 %

+4.25 (+0.54%)

USD0.12B
IHF iShares U.S. Healthcare P.. 0.00 % 0.42 %

+3.49 (+1.25%)

USD1.49B
ACWF iShares MSCI Global Multi.. 0.00 % 0.35 %

+0.73 (+2.22%)

USD0.11B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.74 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

N/A

USD0.05B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.72 %

+0.06 (+0.51%)

USD0.06B
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

+6.20 (+6.40%)

USD0.13B
XFS:CA iShares Edge MSCI Multifa.. 0.00 % 0.51 %

+0.33 (+0.97%)

USD0.03B
XFA:CA iShares Edge MSCI Multifa.. 0.00 % 0.51 %

+0.41 (+1.24%)

USD7.39M
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.13 %

+0.86 (+2.06%)

USD0.15B
RYH Invesco S&P 500® Equal W.. 0.00 % 0.40 %

+6.01 (+2.13%)

USD0.92B
RDVY First Trust Rising Divide.. 0.00 % 0.50 %

+1.11 (+2.53%)

USD8.52B
PBI Pitney Bowes Inc 0.00 % 0.00 %

+0.09 (+2.85%)

USD0.56B
LRGF iShares U.S. Equity Facto.. 0.00 % 0.08 %

+0.96 (+2.31%)

USD1.03B
FDWM Fidelity Covington Trust .. 0.00 % 0.59 %

+0.40 (+2.27%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Healthcare Plans)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.30% N/A N/A N/A N/A
Dividend Return 0.55% N/A N/A N/A N/A
Total Return 3.85% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 30.24% N/A N/A N/A N/A
Dividend Return 1.31% N/A N/A N/A N/A
Total Return 31.56% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 152.77% N/A N/A N/A N/A
Dividend Return 9.76% N/A N/A N/A N/A
Total Return 162.53% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 20.52% 63% D 83% B
Dividend Return 1.33% 60% D- 33% F
Total Return 21.85% 63% D 83% B
Risk Return Profile  
Volatility (Standard Deviation) 20.05% 63% D 55% F
Risk Adjusted Return 108.97% 75% C 97% A+
Market Capitalization 116.34B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Healthcare Plans)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.99 N/A N/A N/A N/A
Price/Book Ratio 3.23 N/A N/A N/A N/A
Price / Cash Flow Ratio 13.91 N/A N/A N/A N/A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 17.79% N/A N/A N/A N/A
Return on Invested Capital -3.26% N/A N/A N/A N/A
Return on Assets 5.81% N/A N/A N/A N/A
Debt to Equity Ratio 58.67% N/A N/A N/A N/A
Technical Ratios  
Dividend Yield 1.08% N/A N/A N/A N/A
Short Ratio 2.00 N/A N/A N/A N/A
Short Percent 0.94% N/A N/A N/A N/A
Beta 0.97 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike